Status:
COMPLETED
Effects of the COVID-19 Pandemic on Fibromyalgia Patients
Lead Sponsor:
Kars State Hospital
Conditions:
Fibromyalgia
Chronic Low-back Pain
Eligibility:
All Genders
18-65 years
Brief Summary
In this study, the effects of the symptoms related to the diseases of patients with fibromyalgia during the COVID-19 pandemic, their limitations in their social and business life, the need for differe...
Detailed Description
Psychological stress caused by the COVID-19 pandemic may contribute to the severity and duration of physical pain. However, when added to the economic stress due to social isolation, pain may worsen i...
Eligibility Criteria
Inclusion
- patients aged between 18 and 65 years
- patients who have low back pain lasting at least 3 months and started before pandemic
- patients diagnosed with fibromyalgia for at least 6 months
Exclusion
- patients diagnosed with major depression
- patients who have a history of back surgery, fracture, infection, spinal stenosis
- patients with malignancy
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 25 2021
Estimated Enrollment :
1360 Patients enrolled
Trial Details
Trial ID
NCT04730934
Start Date
January 1 2021
End Date
February 25 2021
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Çam and Sakura City Hospital
Istanbul, Turkey (Türkiye)